STEVEN KIM: Open Payments
NPI 1659040574 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,615 in 197 payments from 18 companies in 2025. Trend: 2023 $3,159 · 2024 $2,968 · 2025 $3,615
Food & beverage: $3,504Education: $111
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $456 |
| Axsome Therapeutics, Inc. | 14 | $432 |
| Teva Pharmaceuticals USA, Inc. | 15 | $365 |
| E.R. Squibb & Sons, L.L.C. | 20 | $328 |
| Otsuka America Pharmaceutical, Inc. | 17 | $321 |
| ABBVIE INC. | 22 | $275 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $274 |
| Supernus Pharmaceuticals, Inc. | 15 | $240 |
| Vanda Pharmaceuticals Inc. | 11 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $165 |
Products named: INGREZZA, Auvelity, COBENFY, VRAYLAR, CAPLYTA, Qelbree, FANAPT, REXULTI.
Industry payments across TX — which companies pay providers there.
